Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
6 Months Ended | |
|---|---|---|
Aug. 31, 2021 |
Aug. 31, 2020 |
|
| Research and development expenses | $ 13,922,632 | $ 267,743 |
| Restricted Stock Units | ||
| Antidilutive securities | 4,170,278 | 4,313,750 |
| Warrants | ||
| Antidilutive securities | 11,684,418 | 4,884,331 |
| Stock Options [Member] | ||
| Antidilutive securities | 1,587,081 | 1,587,081 |